Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Share Issue/Capital Change 2021

Sep 7, 2021

3695_rns_2021-09-07_0d44942c-0d7e-498d-9c83-0ab7e07a6faa.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Share capital increase from exercise of warrants

Share capital increase from exercise of warrants

As a consequence of exercise of 467,864 warrants in Vaccibody AS, the share capital of Vaccibody AS has increased by NOK 4,678.64 from NOK 2,865,438.45 to NOK 2,870,117.09. The number of outstanding shares in the company has increased by 467,864 from 286,543,845 to 287,011,709, each with a par value of NOK 0.01. The warrants were exercised by an employee at a strike price of NOK 2.50 per share.